Altered Expression of Sirtuin-1 or Its Inhibitor Deleted in Breast Cancer-1 Affects Premalignant Changes in Mouse Exocrine Tissue and Growth of Human Pancreatic Ductal Adenocarcinoma Cells

被引：0
|
作者：
Wauters, E. [1 ]
Sanchez-Arevalo Lobo, V. J. [2 ]
Pinho, A. V. [3 ]
Mawson, A. V. [3 ]
Liu, T. [4 ]
Serrano, M.
Bouwens, L. [1 ]
Real, F. X. [2 ]
Biankin, A. V. [3 ]
Rooman, I. [3 ]
机构：
[1] VUB, Cell Differentiat Unit, Brussels, Belgium
[2] CNIO, Programa Patol Mol, Madrid, Spain
[3] Garvan Inst, Darlinghurst, NSW, Australia
[4] Childrens Canc Inst Australia Med Res, Randwick, NSW, Australia
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)71348-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
706
引用
收藏
页码：S167 / S167
页数：1
相关论文
共 19 条
  • [1] Upregulated Histone Deacetylase 1 Expression in Pancreatic Ductal Adenocarcinoma and Specific SiRNA Inhibits the Growth of Cancer Cells
    Gao, Dao-Jian
    Xu, Min
    Zhang, Yu-Qi
    Du, Yi-Qi
    Gao, Jun
    Gong, Yan-Fang
    Man, Xiao-Hua
    Wu, Hong-Yu
    Jin, Jing
    Xu, Guo-Ming
    Li, Zhao-Shen
    PANCREAS, 2010, 39 (07) : 994 - 1001
  • [2] Protein and mRNA expression of tissue factor pathway inhibitor-1 (TFPI-1) in breast, pancreatic and colorectal cancer cells
    M. A. Kurer
    Molecular Biology Reports, 2007, 34 : 221 - 224
  • [3] Protein and mRNA expression of tissue factor pathway inhibitor-1 (TFPI-1) in breast, pancreatic and colorectal cancer cells
    Kurer, M. A.
    MOLECULAR BIOLOGY REPORTS, 2007, 34 (04) : 221 - 224
  • [4] Tissue inhibitor of metalloproteinases-1 stimulates gene expression in MDA-MB-435 human breast cancer cells by means of its ability to inhibit metalloproteinases
    Porter, JF
    Sharma, S
    Wilson, DL
    Kappil, MA
    Hart, RP
    Denhardt, DT
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 (02) : 185 - 193
  • [5] Tissue Inhibitor of Metalloproteinases-1 Stimulates Gene Expression in MDA-MB-435 Human Breast Cancer Cells by Means of its Ability to Inhibit Metalloproteinases
    Joseph F. Porter
    Shashi Sharma
    Donna L. Wilson
    Maya A. Kappil
    Ronald P. Hart
    David T. Denhardt
    Breast Cancer Research and Treatment, 2005, 94 : 185 - 193
  • [6] Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model
    Ye, Jingjia
    Kawaguchi, Makiko
    Haruyama, Yukihiro
    Kanemaru, Ai
    Fukushima, Tsuyoshi
    Yamamoto, Koji
    Lin, Chen-Yong
    Kataoka, Hiroaki
    CANCER SCIENCE, 2014, 105 (01) : 44 - 51
  • [7] Binding of the transcription factor Slug to the L1CAM promoter is essential for transforming growth factor-β1 (TGF-β)-induced L1CAM expression in human pancreatic ductal adenocarcinoma cells
    Geismann, Claudia
    Arlt, Alexander
    Bauer, Iris
    Pfeifer, Marco
    Schirmer, Uwe
    Altevogt, Peter
    Mueerkoesteri, Susanne Sebens
    Schaefer, Heiner
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 38 (01) : 257 - 266
  • [8] Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and affects expression of cyclin D1 and MMP-9
    Yuan, Zhu
    Sanders, Andrew J.
    Ye, Lin
    Wang, Yu
    Jiang, Wen G.
    ONCOLOGY REPORTS, 2011, 26 (01) : 237 - 245
  • [9] EPIDERMAL GROWTH-FACTOR INCREASES UROKINASE, UROKINASE RECEPTOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 EXPRESSION IN HUMAN BREAST-CANCER CELLS
    TRIPATHY, D
    COHEN, R
    SHUMAN, M
    BENZ, CC
    CLINICAL RESEARCH, 1992, 40 (02): : A211 - A211
  • [10] EGF-DEPENDENT GROWTH-INHIBITION IN MDA-468 HUMAN BREAST-CANCER CELLS IS CHARACTERIZED BY LATE G1 ARREST AND ALTERED GENE-EXPRESSION
    PRASAD, KAN
    CHURCH, JG
    EXPERIMENTAL CELL RESEARCH, 1991, 195 (01) : 20 - 26
12